Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
October 30, 2024 09:30 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
October 18, 2024 09:17 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
Revance Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
November 03, 2021 11:21 ET
|
Portnoy Law
LOS ANGELES, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) investors that the firm has initiated an...